0001019056-18-000956.txt : 20180813 0001019056-18-000956.hdr.sgml : 20180813 20180813164548 ACCESSION NUMBER: 0001019056-18-000956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180809 FILED AS OF DATE: 20180813 DATE AS OF CHANGE: 20180813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mitchell Shawnte CENTRAL INDEX KEY: 0001749432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 181012821 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 ownership.xml X0306 4 2018-08-09 0 0001671584 Aptevo Therapeutics Inc. APVO 0001749432 Mitchell Shawnte 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 0 1 0 0 SVP, GC and Corporate Affairs Common Stock 2018-08-09 4 M 0 1630 A 76135 D Common Stock 2018-08-09 4 F 0 383 4.50 D 75752 D Restricted Stock Units 2018-08-09 4 M 0 1630 0 D Common Stock 1630 6787 D Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis. On August 10, 2015, the reporting person was granted 4,892 restricted stock units. 1,631 shares of common stock underlying the restricted stock units vested on each of August 9, 2016 and August 9, 2017, and 1,630 vested on August 9, 2018. /s/ Carl A. Valenstein, attorney-in-fact 2018-08-13